PFIZER INC
8-K, 2000-04-18
PHARMACEUTICAL PREPARATIONS
Previous: PFIZER INC, 8-K, 2000-04-18
Next: PFIZER INC, 8-K, 2000-04-18

 

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 

     

FORM 8-K

   
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE 
SECURITIES EXCHANGE ACT OF 1934 
     
Date of report: April 18, 2000 
Date of earliest event reported: April 18, 2000
 
PFIZER INC.
(Exact name of registrant as specified in its charter) 
 
Delaware
(State or other jurisdiction of incorporation)
1-3619
(Commission File Number)
13-5315170
(I.R.S. Employer Identification No.)
 
235 East 42nd Street 
New York, New York 
(Address of principal executive offices)
10017
(Zip Code)
 
Registrant's telephone number, including area code: 
(212) 573-2323 
 

 
 
 
 

Item 5. Other Events

Attached and incorporated herein by reference an Exhibit 99.1 is a copy of a press release of Pfizer Inc. dated April 18, 2000 announcing the senior leadership team.


 
 

Item 7(c). Exhibits

99.1

Press Release of Pfizer Inc. dated April 18, 2000 announcing the senior leadership team.


 
 

SIGNATURE

Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.

 
 
 

PFIZER INC.

Dated: April 18, 2000
 
 

By: /s/ MARGARET M. FORAN
Name: Margaret M. Foran 
Title: Vice President - Corporate Governance 


 
 
 
 

 
 

Index to Exhibits

99.1

Press Release of Pfizer Inc. dated April 18, 2000 announcing the senior leadership team.


 
 
 
 
 


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission